Patrick Trucchio (H.C. Wainwright) — Analyst Ratings, Accuracy & Track Record

Q: How accurate are Patrick Trucchio's stock ratings?

About 59% of Patrick's ratings were profitable over a one-year hold, with an average return of +5.5% per rating, measured by 13Foresight from historical prices.

Q: How is Patrick ranked?

Patrick Trucchio is ranked #1974 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

Analyst Tracker/Patrick Trucchio

Patrick Trucchio

H.C. Wainwright

Wall Street Analyst

★★☆☆☆

#1974

on 13Foresight · ranked by our own returns

59%

Success Rate

+6.6%

Average Return

35 of 59 calls profitable · -2.3% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compare To ⓘ

📈 Across the calls we could measure, roughly 59% of Patrick Trucchio's ratings turned a profit when each position was held for 2 year — averaging +6.6% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

408 Buy 1 Hold 0 Sell

Patrick's Stock Coverage 42 ratings · 2026-07-10

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	2-Yr Return
MRKR Marker Therapeutics	Jul 09, 2026	BUY	Strong Buy +799.8% avg upside 9 analysts	$10.00 532.93% Upside	·
HELP Helus Pharma	Jul 09, 2026	BUY	Strong Buy +548.9% avg upside 12 analysts	$70.00 955.79% Upside	·
DTIL Precision BioSciences	Jul 09, 2026	BUY	Strong Buy +158.2% avg upside 12 analysts	$60.00 555.01% Upside	·
IVVD Invivyd	Jul 08, 2026	BUY	Buy +898.8% avg upside 8 analysts	$10.00 1144.22% Upside	+0.0%
CMPS COMPASS Pathways	Jul 08, 2026	BUY	Strong Buy +62.5% avg upside 19 analysts	$70.00 414.62% Upside	-0.9%
BEAM Beam Therapeutics	Jul 07, 2026	BUY	Strong Buy +42.9% avg upside 25 analysts	$80.00 123.29% Upside	-2.7%
ALGS Aligos Therapeutics	Jul 07, 2026	BUY	Buy +581.3% avg upside 11 analysts	$50.00 638.47% Upside	·
ALNY Alnylam Pharma	Jul 06, 2026	BUY	Strong Buy +8.5% avg upside 51 analysts	$470.00 50.23% Upside	+16.0%
VYGR Voyager Therapeutics	Jul 06, 2026	BUY	Strong Buy +288.7% avg upside 23 analysts	$25.00 579.42% Upside	·
ARWR Arrowhead Pharmaceuticals	Jul 06, 2026	BUY	Buy -21.5% avg upside 26 analysts	$100.00 19.13% Upside	-0.9%
QURE uniQure	Jun 29, 2026	BUY	Strong Buy +33.9% avg upside 29 analysts	$80.00 79.89% Upside	-1.9%
NRXP NRX Pharmaceuticals	Jun 25, 2026	BUY	Strong Buy +885.8% avg upside 5 analysts	$45.00 994.83% Upside	·
ANRO Alto Neuroscience, Inc.	Jun 25, 2026	BUY	Strong Buy +11.1% avg upside 13 analysts	$50.00 80.97% Upside	+3.1%
ATAI Atai Beckley N.V.	Jun 25, 2026	BUY	Strong Buy +154.1% avg upside 16 analysts	$25.00 369.03% Upside	+6.6%
DRUG Bright Minds Biosciences	Jun 25, 2026	BUY	Strong Buy +72.8% avg upside 10 analysts	$145.00 85.52% Upside	·
GOSS Gossamer Bio	Jun 25, 2026	BUY	Hold +4048.7% avg upside 17 analysts	$2.00 1042.91% Upside	·
DFTX Definium Therapeutics	Jun 23, 2026	BUY	Strong Buy -10.6% avg upside 20 analysts	$70.00 44.45% Upside	+33.9%
FTH Faeth Therapeutics	Jun 23, 2026	BUY	Strong Buy +27.2% avg upside 13 analysts	$60.00 84.33% Upside	·
HRMY Harmony Biosciences Holdings	Jun 23, 2026	BUY	Strong Buy +22.9% avg upside 13 analysts	$55.00 43.86% Upside	+12.0%
AGMB AgomAb Therapeutics NV ADR	Jun 22, 2026	BUY	Strong Buy +117.9% avg upside 4 analysts	$35.00 168.55% Upside	·
SLN Silence Therapeutics	Jun 17, 2026	BUY	Buy +229.3% avg upside 10 analysts	$75.00 660.57% Upside	·
GB:FARN Faron Pharmaceuticals Oy	Jun 17, 2026	BUY	Strong Buy +2309.7% avg upside 1 analyst	$1000.00 2309.72% Upside	·
PHVS Pharvaris	Jun 16, 2026	BUY	Strong Buy +26.0% avg upside 14 analysts	$60.00 66.81% Upside	+15.9%
SGMOQ Sangamo Therapeutics	Jun 09, 2026	HOLD	Buy +13214.5% avg upside 16 analysts	—	·
ALT Altimmune	Jun 03, 2026	BUY	Strong Buy +761.0% avg upside 20 analysts	$20.00 541.11% Upside	·
IMCR Immunocore Holdings	Jun 03, 2026	BUY	Strong Buy +93.8% avg upside 22 analysts	$100.00 202.35% Upside	+16.5%
VIR Vir Biotechnology	Jun 03, 2026	BUY	Strong Buy +152.8% avg upside 16 analysts	$20.00 93.50% Upside	+18.9%
ASMB Assembly Biosciences	Jun 03, 2026	BUY	Strong Buy +21.1% avg upside 10 analysts	$50.00 79.46% Upside	·
ONCY Oncolytics Biotech	May 29, 2026	BUY	Strong Buy +696.5% avg upside 12 analysts	$10.00 986.87% Upside	-18.2%
GHRS GH Research	May 19, 2026	BUY	Strong Buy +35.4% avg upside 11 analysts	$65.00 139.02% Upside	+22.4%
MIST Milestone Pharmaceuticals	Apr 02, 2025	BUY	Strong Buy +539.0% avg upside 7 analysts	$10.00 663.41% Upside	+61.9%
QTTB Q32 Bio	May 15, 2023	BUY	Buy +310.2% avg upside 24 analysts	$360.00 2759.47% Upside	-90.5%
BNTC Benitec Biopharma	Feb 10, 2023	HOLD	Strong Buy +97.1% avg upside 13 analysts	—	+137.0%
TSE:PHRM PharmaTher Holdings Ltd	Feb 10, 2023	HOLD	Hold 1 analyst	—	·
GB:AGY Allergy Therapeutics	Nov 02, 2022	BUY	Strong Buy +31006.1% avg upside 2 analysts	$46.03 586.97% Upside	·
DE:EVT Evotec	Mar 27, 2020	BUY	Strong Buy +234.7% avg upside 8 analysts	$33.00 561.22% Upside	·
SUPN Supernus Pharmaceuticals	Nov 08, 2019	HOLD	Strong Buy +10.8% avg upside 7 analysts	$24.00 50.77% Downside	+54.5%
ENTA Enanta Pharmaceuticals	Sep 18, 2019	BUY	Buy +130.1% avg upside 17 analysts	$130.00 812.28% Upside	-17.4%
PRGO Perrigo Company	Nov 13, 2018	HOLD	Buy +552.2% avg upside 20 analysts	$72.00 591.71% Upside	-22.5%
IRWD Ironwood Pharma	Apr 19, 2018	BUY	Hold +153.8% avg upside 23 analysts	$25.00 435.37% Upside	-29.9%
INVA Innoviva	Apr 19, 2018	BUY	Strong Buy +28.7% avg upside 12 analysts	$22.00 0.99% Downside	-19.3%
KMB Kimberly Clark	Dec 23, 2014	BUY	Buy +14.2% avg upside 30 analysts	$125.00 13.75% Upside	+3.5%

🔒 37 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Patrick Trucchio — Frequently Asked Questions

How accurate are Patrick Trucchio's stock ratings?

Based on the calls 13Foresight could measure, about 59% of Patrick's ratings were profitable over a one-year hold, with an average return of +5.5% per rating, or -0.7% versus the S&P 500. We score every analyst the same way, from historical prices.

How is Patrick ranked on 13Foresight?

Patrick Trucchio is currently ranked #1974 with a 2-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Patrick cover?

Patrick most recently has ratings on MRKR, HELP, DTIL, IVVD, CMPS, BEAM, ALGS, ALNY, VYGR, ARWR, QURE, NRXP and 30 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Rating Distribution

Welcome to 13Foresight!